If you’ve been keeping a close eye on share tips 2025, then don’t miss this weekly round-up of the top stocks to consider for your portfolio.
The MoneyWeek share tips 2025 guide pulls together some of the best stocks from some of the top share tipsters around.
As well as the UK financial pages, we look at publications across the pond for investors who want to diversify their holdings internationally.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
We look at where to invest in 2025 – from big tech stocks and top funds to finding value in the FTSE 100.
This list is updated weekly.
Share tips 2025: top picks of the week
Four to buy
1. Judges Scientific (LSE: JDG)
The Telegraph
Judges Scientific is “good value for money on a long-term view”. Shares in the designer and producer of scientific instruments have fallen 44% in a year, and the company posted lower annual revenue and profit due to a tough trading environment. Yet earnings are expected to rise over the next two years, and it has the capacity to pursue acquisitions to boost long-term earnings and overcome operating difficulties. Judges is a “worthwhile contrarian pick”. 6,140p
2. WH Smith (LSE: SMWH)
Investors’ Chronicle
WH Smith’s exit from Britain’s high streets after more than 230 years “looks like the right move”. The disposal of the high-street chain to private equity firm Modella Capital for £76 million should help WH Smith focus on its more profitable travel business and improve its margins and balance sheet. The shares, which have dipped owing to fears that “a more belligerent US administration could deter tourists, should eventually re-rate”. 899p
3. Wise Group (LSE: WISE)
Shares
Wise aims to handle £1 trillion in cross-border payments annually compared with £118 billion last year, and has the potential to grow further in an expanding market. The payments provider has captured market share from traditional banks owing to its focus on customers and lower fees, saving its customers an estimated £2 billion annually. Increased investment in pricing is expected to bolster margins and underlying income. Wise’s relative scale advantage, infrastructure, and ability to share efficiencies with clients, “should make it a sustainable winner” in the sector. 977p
4. Capital (LSE: CAPD)
This is Money
Mining services group Capital was hit by some contracts being delayed last year. Results fell short of hopes, and the CEO resigned. Chairman Jamie Boyton is now in charge and is putting Capital back on track. It is working on the Nevada Gold Mines project in the US and has won new contracts, including one for a new mine in Pakistan. Sales and profits are set to fall this year, but recover in 2026. “Investors who buy now… should reap the benefits.”68p
One to sell
Billington (LSE: BILN)
Investors’ Chronicle
Billington’s performance last year was resilient despite challenging market conditions. The steel and construction specialist benefited from operational efficiencies and a robust balance sheet. However, the structural steelwork market remains subdued, with increased pricing pressure leading to Billington reducing full-year pre-tax profit guidance. The annual dividend is expected to be cut too. Although Billington can weather the downturn better than peers and has contracts secured, “investors are likely to remain cautious given the weak UK economic outlook and low business confidence”. “Take profits.” 381p
The rest...
1. Concurrent Technologies (LSE: CNC)
Investors’ Chronicle
Concurrent Technologies makes computers used in military aeroplanes and ships that power radar systems and communication gear. The recent surge in defence spending has bolstered revenue and profits and led to new contracts, including its largest-ever one with a major US defence firm, which should contribute significantly to profits from 2027. Germany’s multibillion-euro spending plan should boost growth. Concurrent’s valuation is expensive, yet given its growth rate and strong balance sheet, it is not “exorbitant”. Buy (162p).
2. Engie (EPA: ENGI)
The Telegraph
France’s Engie owns and operates gas-fired power stations, but has moved heavily into renewables. It boasts predictable earnings and cash flow and a generous dividend. Engie is bolstering new power generation capacity and has upgraded its earnings outlook for the next three years. Fluctuating prices, volatility in the energy market, and the US freeze on green-energy funding are headwinds, but Engie has options elsewhere and smart-money backers. Buy (€19).
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
-
The fastest and slowest places to sell a home – where does your area rank?Average time on the property market before selling a home can vary from 19 days to 62 days, depending on location.
-
Who won the £1 million jackpot in the May Premium Bonds prize draw?NS&I has announced the winners of May’s Premium Bonds prize draw. Who won the £1 million jackpot and how can you find out if you scooped a prize this month?
-
Three British mid-caps that could make 'attractive' investmentsOpinion Charles Luke, manager of the Murray Income Trust, highlights three UK-listed mid-cap companies, as he tells us where he'd put his money
-
LendInvest: a promising fintech firm going cheapOpinion LendInvest has made some mistakes in the past, but it’s now primed for growth, says Rupert Hargreaves
-
The star small and mid-cap stocks income investors have overlookedOpinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
-
Falling revenues and mounting debt spell trouble for Jumia TechnologiesStruggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
-
Chemring Group: an explosive investment opportunity in defenceEuropean states are raising their military spending, and Chemring Group looks well placed to profit
-
Best of British bargains: cash in on undervalued companies in the UK stock marketOpinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
-
PZ Cussons share price down 75% in last decade – why it's one to watchOpinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharmaOpinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
